Mr. Stone served as Executive Vice President of Laboratory Solutions for Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma and healthcare, education and government and advanced technologies industries, until July 2024. Avantor s Laboratory Solutions segment is a multi-billion-dollar business that includes a comprehensive portfolio of products, services and digital solutions to enable insights in life sciences research, diagnostic and quality control workflows and supports Avantor s own research and development initiatives. Mr. Stone joined Avantor in April 2023 as Executive Vice President, Proprietary Research Products and Materials. Prior to joining Avantor, Mr. Stone served as the President of DuPont s (NYSE: DD) Mobility and Materials segment, a leading provider of engineered polymers, performance resins and advanced solutions serving the electronics, industrial, consumer and transportation markets, from 2016 until November 2022 when DuPont divested the majority of the business. From 2012 until 2015, Mr. Stone served as a Director of Investor Relations for DuPont, during which time he gained extensive experience interacting with institutional investors and analysts. Prior to that, Mr. Stone served as a DuPont Regional Director in Asia, based in Shanghai, China. Mr. Stone presently serves as a member of the board of directors of Ansell Corporation (ASX: ANN), a leading Australian-based global manufacturer of personal protective equipment (PPE), specializing in advanced, high-performance gloves, protective clothing, and safety solutions for healthcare and industrial sectors. The Board believes that Mr. Stone s executive-level experience with a global company, his investor relations and corporate development experience and understanding of end markets aligned with the Company s strategies, make him well qualified to serve as a director.